Professor Mark Woodward is one of the world’s most widely published and highly-cited biostatistician/epidemiologists. He has played a leadership role in many landmark research projects in related fields, including sex/gender differences in non-communicable diseases; epidemiology of cardiovascular diseases in Asia; vascular risk scores; prevention of complications of diabetes; causes and outcomes of renal disease; and the design and analysis of clinical trials. All of these have involved producing innovative methodology and, in each area, the outputs have led to changes in major international clinical guidelines.